  Objective: Proton therapy offers an advantageous dose distribution compared
to the photon therapy, since it deposits most of the energy at the end of
range, namely the Bragg peak (BP). Protoacoustic technique was developed to in
vivo determine the BP locations. However, it requires large dose delivery to
the tissue to obtain an averaged acoustic signal with a sufficient signal to
noise ratio (SNR), which is not suitable in clinics. We propose a deep
learning-based technique to acquire denoised acoustic signals and reduce BP
range uncertainty with much lower doses. Approach: Three accelerometers were
placed on the distal surface of a cylindrical polyethylene (PE) phantom to
collect protoacoustic signals. In total 512 raw signals were collected at each
device. Device-specific stack autoencoder (SAE) denoising models were trained
to denoise the input signals, which were generated by averaging 1, 2, 4, 8, 16,
or 32 raw signals. Both supervised and unsupervised learning training
strategies were tested for comparison. Mean squared error (MSE),
signal-to-noise ratio (SNR) and the Bragg peak (BP) range uncertainty were used
for model evaluation. Main results: After SAE denoising, the MSE was
substantially reduced, and the SNR was enhanced. Overall, the supervised SAEs
outperformed the unsupervised SAEs in BP range verification. For the high
accuracy detector, it achieved a BP range uncertainty of 0.20 +/- 3.44 mm by
averaging over 8 raw signals, while for the other two low accuracy detectors,
they achieved the BP uncertainty of 1.44 +/- 6.45 mm and -0.23 +/- 4.88 mm by
averaging 16 raw signals, respectively. Significance: We have proposed a deep
learning based denoising method to enhance the SNR of protoacoustic
measurements and improve the accuracy in BP range verification, which greatly
reduces the dose and time for potential clinical applications.
